StockData
Pharming Group N.V. logo

Pharming Group N.V. (PHAR) stock

PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30
$12.48+0.42 (+3.51%)

Close on Nov 18, 2026Market cap $875.92MP/E 312.1Yield –

Pharming free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was $53.96M. The highest annual figure on record is $78.97M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$53.96M–
FY2024Dec 31, 2024-$2.59M–
FY2023Dec 31, 2023-$18.74M-188.9%
FY2022Dec 31, 2022$21.08M-22.2%
FY2021Dec 31, 2021$27.10M-65.7%
FY2020Dec 31, 2020$78.97M+10.4%
FY2019Dec 31, 2019$71.50M–

More Pharming figures

See a number that looks wrong?